Abstract:Description Since the early 2000s, there has been a rapid decline in colorectal cancer (CRC) mortality, due in large part to screening and removal of precancerous polyps. Despite these improvements, CRC remains the second leading cause of cancer deaths in the United States, with approximately 53,000 deaths projected in 2023. The aim of this American Gastroenterological Association (AGA) Clinical Practice Update Expert Review was to describe how individuals should be risk-stratified for CRC screening and post-polypectomy surveillance and to highlight opportunities for future research to fill gaps in the existing literature. Methods This Expert Review was commissioned and approved by the American Gastroenterological Association (AGA) Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the CPUC and external peer review through standard procedures of Gastroenterology . These Best Practice Advice statements were drawn from a review of the published literature and from expert opinion. Because systematic reviews were not performed, these Best Practice Advice statements do not carry formal ratings regarding the quality of evidence or strength of the presented considerations. Best Practice Advice Statements Best Practice Advice 1 All individuals with a first-degree relative (defined as a parent, sibling, or child) who was diagnosed with CRC, particularly before the age of 50 years, should be considered at increased risk for CRC. Best Practice Advice 2 All individuals without a personal history of CRC, inflammatory bowel disease, hereditary CRC syndromes, other CRC predisposing conditions, or a family history of CRC should be considered at average risk for CRC. Best Practice Advice 3 Individuals at average risk for CRC should initiate screening at age 45 years and individuals at increased risk for CRC due to having a first-degree relative with CRC should initiate screening 10 years before the age at diagnosis of the youngest affected relative or age 40 years, whichever is earlier. Best Practice Advice 4 Risk stratification for initiation of CRC screening should be based on an individual's age, a known or suspected predisposing hereditary CRC syndrome, and/or a family history of CRC. Best Practice Advice 5 The decision to continue CRC screening in individuals older than 75 years should be individualized, based on an assessment of risks, benefits, screening history, and comorbidities. Best Practice Advice 6 Screening options for individuals at average risk for CRC should include colonoscopy, fecal immunochemical test, flexible sigmoidoscopy plus fecal immunochemical test, multitarget stool DNA fecal immunochemical test, and computed tomography colonography, based on availability and individual preference. Best Practice Advice 7 Colonoscopy should be the screening strategy used for individuals at increased CRC risk. Best Practice Advice 8 The decision to continue post-polypectomy surveillance for individuals older than 75 years should be individualized, based on an assessment of risks, benefits, and comorbidities. Best Practice Advice 9 Risk-stratification tools for CRC screening and post-polypectomy surveillance that emerge from research should be examined for real-world effectiveness and cost-effectiveness in diverse populations (eg, by race, ethnicity, sex, and other sociodemographic factors associated with disparities in CRC outcomes) before widespread implementation.

Abstract IA005: Risk prediction in colorectal cancer screening: Reflections on the current status

Abstract 2317: Development and validation of a colorectal cancer prediction model: A nationwide cohort-based study

Abstract IA012: Risk factors for early-onset colorectal cancer

Optimal Strategies for Colorectal Cancer Screening

Evaluating the use of environmental and polygenic risk scores to inform colorectal cancer risk-based surveillance intervals

Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline

The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis

AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review

Adopting Non-invasive Approaches into Precision Colorectal Cancer Screening

Colorectal Cancer Screening Decision Based on Predicted Risk: Protocol for a Pilot Randomized Controlled Trial

Targeted Screening For Colorectal Cancer In High-Risk Individuals

Predicting Early-Onset Colorectal Cancer in Individuals Below Screening Age Using Machine Learning and Real-World Data

The Use of Blood-Based Biomarkers in the Prediction of Colorectal Neoplasia at the Time of Primary Screening Colonoscopy Among Average-Risk Patients: A Systematic Literature Review

Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults

Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening

Current and future colorectal cancer screening strategies

Risk factors and prediction algorithm for advanced neoplasia on screening colonoscopy for average-risk individuals

A novel colorectal cancer screening framework with feature interpretability to identify high‐risk populations for colonoscopy

Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies

Predicting Risk of Colorectal Cancer After Adenoma Removal in a Large, Community-based Setting.

Evaluation of a risk index for advanced proximal neoplasia of the colon